138 related articles for article (PubMed ID: 28648154)
1. [The cause of cytopenia of undetermined significance can often be found by using next generation sequencing].
Hansen JW; Husby S; Grønbæk K
Ugeskr Laeger; 2017 Jun; 179(25):. PubMed ID: 28648154
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic cytopenia of undetermined significance and the minimal criteria for a diagnosis of myelodysplastic syndrome.
Pavlu J; Emmerson J; Marks AJ; Bain BJ
Leuk Lymphoma; 2011 Mar; 52(3):515-6. PubMed ID: 21323527
[TBL] [Abstract][Full Text] [Related]
3. How I investigate Clonal cytogenetic abnormalities of undetermined significance.
Tang G; Medeiros LJ; Wang SA
Int J Lab Hematol; 2018 Aug; 40(4):385-391. PubMed ID: 29624895
[TBL] [Abstract][Full Text] [Related]
4. Significance of myelodysplastic syndrome-associated somatic variants in the evaluation of patients with pancytopenia and idiopathic cytopenias of undetermined significance.
Fernandez-Pol S; Ma L; Ohgami RS; Arber DA
Mod Pathol; 2016 Sep; 29(9):996-1003. PubMed ID: 27255165
[TBL] [Abstract][Full Text] [Related]
5. Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasia.
Jajosky AN; Sadri N; Meyerson HJ; Oduro KA; Kelkar A; Fitzgerald B; Tomlinson B; Moore EM; Beck RC
Eur J Haematol; 2021 Apr; 106(4):500-507. PubMed ID: 33386622
[TBL] [Abstract][Full Text] [Related]
6. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.
Kohlmann A; Bacher U; Schnittger S; Haferlach T
Leuk Lymphoma; 2014 Aug; 55(8):1725-34. PubMed ID: 24144312
[TBL] [Abstract][Full Text] [Related]
7. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
[TBL] [Abstract][Full Text] [Related]
8. Mutations in idiopathic cytopenia of undetermined significance assist diagnostics and correlate to dysplastic changes.
Hansen JW; Westman MK; Sjö LD; Saft L; Kristensen LS; Ørskov AD; Treppendahl M; Andersen MK; Grønbaek K
Am J Hematol; 2016 Dec; 91(12):1234-1238. PubMed ID: 27717004
[TBL] [Abstract][Full Text] [Related]
9. Unexplained chronic cytopenia: is it idiopathic cytopenia of undetermined significance or myelodysplastic syndrome.
Ramachandran P; Erdinc B; Sahni S; Avezbakiyev B
BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31630129
[TBL] [Abstract][Full Text] [Related]
10. Validation of a scoring system to establish the probability of myelodysplastic syndrome in patients with unexplained cytopenias or macrocytosis.
Rauw J; Wells RA; Chesney A; Reis M; Zhang L; Buckstein R
Leuk Res; 2011 Oct; 35(10):1335-8. PubMed ID: 21704372
[TBL] [Abstract][Full Text] [Related]
11. Characterization of TP53 mutations in clonal cytopenia of undetermined significance.
Wang W; Routbort MJ; Ok CY; Patel KP; Sun Y; Kanagal-Shamanna R; Medeiros LJ; Wang SA
Am J Hematol; 2017 Aug; 92(8):E175-E177. PubMed ID: 28494520
[No Abstract] [Full Text] [Related]
12. The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP).
Malcovati L; Cazzola M
Hematology Am Soc Hematol Educ Program; 2015; 2015():299-307. PubMed ID: 26637737
[TBL] [Abstract][Full Text] [Related]
13. Wilms' tumor-1 transcript in peripheral blood helps diagnose acute myeloid leukemia and myelodysplastic syndrome in patients with pancytopenia.
Yamauchi T; Matsuda Y; Takai M; Tasaki T; Hosono N; Negoro E; Ikegaya S; Takagi K; Kishi S; Yoshida A; Urasaki Y; Ueda T
Anticancer Res; 2012 Oct; 32(10):4479-83. PubMed ID: 23060576
[TBL] [Abstract][Full Text] [Related]
14. ASXL1 is a molecular predictor in idiopathic cytopenia of undetermined significance.
Shin DY; Park JK; Kim SM; Im K; Kim JA; Kim SY; Hwang SM; Yoon SS; Lee DS
Leuk Lymphoma; 2019 Mar; 60(3):756-763. PubMed ID: 30301403
[TBL] [Abstract][Full Text] [Related]
15. Advances in Diagnosis and Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Pillai RK; Afkhami M
Cancer Treat Res; 2021; 181():1-16. PubMed ID: 34626352
[TBL] [Abstract][Full Text] [Related]
16. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Nardi V; Hasserjian RP
Surg Pathol Clin; 2016 Mar; 9(1):143-63. PubMed ID: 26940274
[TBL] [Abstract][Full Text] [Related]
17. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.
Takahashi K; Wang F; Kantarjian H; Doss D; Khanna K; Thompson E; Zhao L; Patel K; Neelapu S; Gumbs C; Bueso-Ramos C; DiNardo CD; Colla S; Ravandi F; Zhang J; Huang X; Wu X; Samaniego F; Garcia-Manero G; Futreal PA
Lancet Oncol; 2017 Jan; 18(1):100-111. PubMed ID: 27923552
[TBL] [Abstract][Full Text] [Related]
18. Next-Generation Sequencing in Myeloid Neoplasm-Associated Sweet's Syndrome Demonstrates Clonal Relation between Malignant Cells and Skin-Infiltrating Neutrophils.
Passet M; Lepelletier C; Vignon-Pennamen MD; Chasset F; Hirsch P; Battistella M; Duriez P; Sicre de Fontbrune F; Boissel N; Legrand O; Raffoux E; Bagot M; Adès L; Clappier E; Bouaziz JD
J Invest Dermatol; 2020 Sep; 140(9):1873-1876.e5. PubMed ID: 32081610
[No Abstract] [Full Text] [Related]
19. MYC fireworks.
Bruyère H; Gillan T
Blood; 2014 Jan; 123(1):13. PubMed ID: 24527506
[No Abstract] [Full Text] [Related]
20. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia.
Venkatraj VS; Gaidano G; Auerbach AD
Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
